POXEL SA , a biopharmaceutical company focused on the development of innovative drugs to treat metabolic diseases, including type 2...
Read more
Takeda Pharmaceutical Company Limited announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration (FDA)...
Read more
Heptares Therapeutics , the wholly-owned subsidiary of Sosei Group Corporation , describes new insights for drug discovery from the first...
Read more
Allergan, a leading global biopharmaceutical company, announced that it will collaborate with TARGET PharmaSolutions, a clinical data company focused on...
Read more
Roche announced that new data on OCREVUS™ in people with relapsing forms of multiple sclerosis (RMS) and primary progressive MS...
Read more
Allergan, a leading global biopharmaceutical company, announced today that it has entered into a clinical trial agreement with Novartis to...
Read more
Evoke Pharma, Inc. , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases announced that the Company has...
Read more
Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, and Valeo Pharma Inc.,...
Read more
Chugai Pharmaceutical Co., Ltd. announced that Alecensa as an initial (first-line) treatment showed that patients lived significantly longer without disease...
Read more
Novartis announced today that it has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe). The closing...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
